Pharmaceutical

Precision Biosciences gets grant for engineered meganucleases for modifying human mitochondrial dna

Unlock the potential of genetic modification with Precision Biosciences Inc's patented MTEM technology for precise editing of eukaryotic cells. Discover how this mitochondria-targeting engineered meganuclease is revolutionizing genetic research.

May 1, 2024 - 00:00
Unlock the potential of genetic modification with Precision Biosciences Inc's patented MTEM technology for precise editing of eukaryotic cells. Discover how this mitochondria-targeting engineered meganuclease is revolutionizing genetic research.
Read the original article

Tags:

Previous Article

Ionis Pharmaceuticals gets grant for modified oligonucleotide for reducing lRRK2...

Next Article

Corcept Therapeutics gets grant for method of preparing compound of formula i

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

STAT+: Amid fears of superbugs, sales of antibiotics used in food-producing livestock rose last year

STAT+: Amid fears of superbugs, sales of antibiotics us...

Dec 11, 2023

Janssen’s patient programme becomes latest victim of data breach

Janssen’s patient programme becomes latest victim of da...

Sep 7, 2023

Opinion: China’s complicated role in malaria control in Africa

Opinion: China’s complicated role in malaria control in...

May 15, 2023